Westmore · UDRP DecisionSanofi-asiapacific.com
The Panel ordered cancellation of <sanofi-asiapacific.com>. It found the domain confusingly similar to Sanofi’s SANOFI trademark, found no rights or legitimate interests because the Complainant’s prima facie case was unrebutted and the domain carried a risk of implied affiliation, and found bad-faith registration and use based principally on the Respondent’s knowledge of the prima facie well-known mark and use of the domain for a pay-per-click parking page containing advertising links, including links concerning pharmaceutical laboratories.
The timeline behind sanofi-asiapacific.com
Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.
Westmore reconstructs the full history behind sanofi-asiapacific.com — from public RDAP and the Internet Archive — as part of UDRP Intelligence:
The decision illustrates how a domain consisting of a well-known mark plus a regional designation can create not only confusing similarity but also an implied-affiliation concern. Its significance is strengthened by the domain’s use for pay-per-click links connected to the trademark owner’s pharmaceutical field, which supplied a commercial-use basis for the bad-faith finding.
Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.
ARBITRATION AN D MEDIATION CENTER ADMINISTRATIVE PANEL DECISION Sanofi v. Mu Guo Case No. D2023-4135 1. The Parties The Complainant is Sanof i, France, represented by Selarl Marchais & Associés, France. The Respondent is Mu Guo, China. 2. The Domain Name and Registrar The disputed domain name <sanofi-asiapacific.com> is registered with NameCheap, Inc. (the “Registrar”). 3. Procedural History The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on October 4, 2023. On October 4, 2023, the Center transmitted by email to the Registrar a request f or registrar verif ication in connection with the disputed domain name. On October 4, 2023, the Registrar transmitted by email to the Center its verif ication response disclosing registrant and contact information for the disputed domain name which differed from the named Respondent (Privacy Service Provided by Withheld f or Privacy ehf ) and contact inf ormation in the Complaint. The Center sent an email communication to the Complainant on October 12, 2023, providing the registrant and contact information disclosed by the Registrar, and inviting the Complainant to submit an amendment to the Complaint. The Complainant f iled an amendment to the Complaint on October 13, 2023. The Center verif ied that the Complaint together with the amendment to the Complaint satisf ied the f ormal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” o r “UDRP”), the Rules f or Unif orm Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules f or Unif orm Domain Name Dispute Resolution Policy (the “Supplemental Rules”). In accordance with the Rules, paragraphs 2 and 4, the Center f ormally notif ied the Respondent of the Complaint, and the proceedings commenced on October 17, 2023. In accordance with the Rules, paragraph 5, the due date f or Response was November 6, 2023. The Respondent did not submit any response. Accordingly, the Center notif ied the Respondent’s def ault on November 9, 2023. The Center appointed Christian Pirker as the sole panelist in this matter on November 24, 2023. The Panel f inds that it was properly constituted. The Panel has submitted the Statement of Acceptance and page 2 Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7. 4. Factual Background Founded in 2004 by the merger of Aventis and Sanofi-Synthélabo and changed its name to Sanof i in 2011. The Complainant is one of the world’s largest multinational pharmaceutical companies by prescription sales, settled in more than 100 countries, on all 5 continents, employing round 100,000 people. The Complainant has provided evidence of trademark registrations f or SANOFI trademark, such as: - European Union trademark SANOFI number 004182325, filed on December 8, 2004 and registered on February 9, 2006 in classes 01; 09; 10; 16; 38; 41; 42; 44 - International trademark SANOFI number 1092811, registered on August 11, 2011 in classes 01; 09; 10; 16; 38; 41; 42; 44 notably concerning products in pharmaceutical and medical spheres, and designating among others Australia, Georgia, Japan, Korea (Republic of), Cuba, Russian Federation, Iceland, Ukraine etc. - United States of America trademark SANOFI number 85396658, f iled on August 12, 2011, and registered on July 24, 2012, in among others class 05 notably concerning pharmaceutical products The Complainant has also registered numerous domain name since 1995 containing its SANOFI trademark f or its official website including “www.sanofi.com”, “www.sanofi.eu”, “www.sanofi.fr”, “www.sanofi.ch”, etc. to represent the company on the Internet. The Respondent is reportedly located in China. The disputed domain name <sanofi-asiapacific.com> was registered on September 14, 2023, and resolved to a domain name parking website which contains advertising links. 5. Parties’ Contentions A. Complainant The Complainant contends that it has satisfied each of the elements required under the Policy f or a transf er of the disputed domain name. Notably, the Complainant contends that the disputed domain name wholly incorporates the Complainant’s distinctive trademarks in its entirety, is confusingly similar to that mark despite the addition of a descriptive geographical terms, which in the contrary, merely suggests to Internet users that the disputed domain name is related to the Complainant’s activities in the Asia-Pacif ic region. Moreover, the Sanof i trademark is considered as “well-known” in numerous jurisdictions. The Complainant also alleges that the Respondent has not received any authorization by the Complainant to use of the disputed domain name and globally has no rights or legitimate interest in respect of the disputed domain name. Further, the Complainant asserts that the Respondent, given the famous and distinctive nature of the well-known and worldwide trademark SANOFI, the Respondent is likely to have had, at least, constructive, if not actual notice, as to the existence of the Complainant’s marks at the time it registered the disputed domain name. Further, adding a region to the well-known trademark, the Respondent must have been aware of the risk of deception and conf usion that would inevitably arise from the registration of the disputed domain name since it could lead Internet users searching for official information or SANOFI pharmaceutical products to the litigious website. Finally, as the website revert to a domain name parking website, which contains advertisements and links websites provide without doubt income to the Respondent depending on the number of hits that are generated on the page 3 disputed domain name, on a pay per click basis. Consequently, the disputed domain name has been both registered and used intentionally in bad f aith. B. Respondent The Respondent did not reply to the Complainant’s contentions. 6. Discussion and Findings A. Identical or Confusingly Similar It is well accepted that the f irst element f unctions primarily as a standing requirement. The standing (or threshold) test for confusing similarity involves a reasoned but relatively straightforward comparison between the Complainant’s trademark and the disputed domain name. WIPO Overview of WIPO Panel Views on Selected UDRP Questions, Third Edition, (“WIPO Overview 3.0 ”), section 1.7. Based on the available record, the Panel finds the Complainant has shown rights in respect of a trademark or service mark f or the purposes of the Policy. WIPO Overview 3.0 , section 1.2.1. The Panel f inds the entirety of the mark is reproduced within the disputed domain name. Accordingly, the disputed domain name is confusingly similar to the mark for the purposes of the Policy. WIPO Overview 3.0 , section 1.7. Although the addition of other terms here, “asiapacif ic” may bear on assessment of the second and third elements, the Panel finds the addition of such term does not prevent a f inding of confusing similarity between the disputed domain name and the mark for the purposes of the Policy. WIPO Overview 3.0 , section 1.8. Finally, it is standard practice to disregard the Top-Level Domain (“TLD”) suffix under the confusing similarity test, except where the applicable TLD suffix may itself form part of the relevant trademark, which is not the case in the present matter. See WIPO Overview 3.0 , section 1.11. Based on the available record, the Panel f inds the f irst element of the Policy has been established. B. Rights or Legitimate Interests Paragraph 4(c) of the Policy provides a list of circumstances in which the Respondent may demonstrate rights or legitimate interests in a disputed domain name. Although the overall burden of proof in UDRP proceedings is on the complainant, panels have recognized that proving a respondent lacks rights or legitimate interests in a domain name may result in the difficult task of “proving a negative”, requiring information that is of ten primarily within the knowledge or control of the respondent. As such, where a complainant makes out a prima facie case that the respondent lacks rights or legitimate interests, the burden of production on this element shifts to the respondent to come f orward with relevant evidence demonstrating rights or legitimate interests in the domain name (although the burden of proof always remains on the complainant). If the respondent f ails to come f orward with such relevant evidence, the complainant is deemed to have satisfied the second element. WIPO Overview 3.0 , section 2.1. Having reviewed the available record, the Panel finds the Complainant has established a prima facie case that the Respondent lacks rights or legitimate interests in the disputed domain name. The Respondent has not rebutted the Complainant’s prima facie showing and has not come f orward with any relevant evidence demonstrating rights or legitimate interests in the disputed domain name such as those enumerated in the Policy or otherwise. page 4 Furthermore, the composition of the disputed d omain name, wholly incorporating the Complainant’s trademark with the term “asiapacific”, carries a risk of implied af f iliation. See WIPO Overview 3.0 , section 2.5.1. Based on the available record, the Panel f inds the second element of the Policy has been established. C. Registered and Used in Bad Faith The Panel notes that, for the purposes of paragraph 4(a)(iii) of the Po licy, paragraph 4(b) of the Policy establishes circumstances, in particular, but without limitation, that, if found by the Panel to be present, shall be evidence of the registration and use of a domain name in bad f aith. Paragraph 4(b) of the Policy sets out a list of non-exhaustive circumstances that may indicate that a domain name was registered and used in bad faith, but other circumstances may be relevant in assessing whether a respondent’s registration and use of a domain name is in bad f aith. WIPO Overview 3.0 , section 3.2.1. Based on the evidence submitted by the Complainant, the Panel accepts that the trademark SANOFI is prima facie well-known, such f inding remains in view of the absence of a Response (see Birkenstock Orthopädie GmbH & Co. KG v. Chen Yanbing, WIPO Case No . D2010-0746 ). It is a well-established principle that registration of a domain name that is confusingly similar to a well-known trademark by any entity that does not have a relationship with that trademark or its owner can by itself create a presumption of bad f aith (see WIPO Overview 3.0 section 3.1.4). It seems clear to the Panel that the Respondent registered the disputed domain name with full knowledge of the Complainant’s well-known trademark, particularly considering the reputation of the Complainant’s mark and since the trademark is included in its entirety supplemented by a geographical area. Finally, the disputed domain name resolved, at filing of the Complaint, to a parking website which contained advertisements and links websites (among others for pharmaceutical laboratory) that likely provided income to the Respondent depending on the number of hits that were generated on the disputed domain name, on a pay per click basis. As such, the Panel determines that the Respondent has intentionally attempted to attract, for commercial gain, Internet users to its website or other on-line location, by creating a likelihood of conf usion with the Complainant’s trademark as to the source, sponsorship, affiliation, or endorsement of its website or location or of a product or service on its website or its location, which is evidence of bath faith use and registration. Accordingly, the Panel f inds that the Respondent was aware of the Complainant’s trademarks when registering the disputed domain name. In view of the above-mentioned facts, the Panel concludes that the Respondent’s primary motive in relation to the registration and use of the disputed domain name was to capitalize on, or otherwise take advantage of, the Complainant’s trademark rights, by creating a likelihood of conf usion with the Complainant’s mark with the intent to unlawfully profit therefrom (see Arla Foods Amba v. Michael Guthrie, M. Guthrie Building Solutions, WIPO Case No. D2016-2213 ). T he f ailure of the respondent to submit a response and the use of a privacy registration service in combination with apparently incomplete contact inf ormation to such service or a continued concealment of the “true” o r “underlying” registrant conf irms the f inding of an evidence of bad f aith WIPO Overview 3.0, section 3.9. Based on the available record, the Panel finds that the Complainant has established the third element of the Policy. page 5 7. Decision For the f oregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders that the disputed domain name <sanof i-asiapacif ic.com> be cancelled. /Christian Pirker/ Christian Pirker Sole Panelist Date: December 18, 2023
Source of record: WIPO . Reproduced for research; WIPO is the authoritative source.
What Westmore sees around sanofi-asiapacific.com
The decision is only the record. Westmore connects it to the cases, authorities, panelists, parties and domain evidence surrounding it.

A short, grounded explanation drawn only from this decision's record — not legal advice or a prediction.
Grounded in the Westmore record for this decision. Research/informational only — not legal advice or a prediction of any outcome.
The decision is only the beginning.
You've seen what happened. Now discover the deeper intelligence behind the case, the panelist, the parties and the authorities that matter.
Go beyond the public record: see how this case has been cited, find comparable decisions, analyze the panelist and apply the relevant authorities to your Matter.
Westmore Professional · $395/month
Research with UDRP IntelligenceWestmore AI drafts an attorney-review-ready UDRP response from your facts, grounded in the exact panel and closest precedent.
$895 one-time per matter · no subscription required. Self-help drafting aid — not legal advice.
Build your responseWestmore UDRP records draw on WIPO-indexed decisions and are provided for research and informational purposes only. Not legal advice, a clearance opinion, or a prediction of any outcome.